Literature DB >> 11222346

Incidence of blindness due to diabetic eye disease in Fife 1990-9.

T G Cormack, B Grant, M J Macdonald, J Steel, I W Campbell.   

Abstract

AIMS: In the light of goals for reducing blindness due to diabetes, published in the St Vincent Declaration, 1989, the aim of this study was to find the incidence and prevalence of blindness in the diabetic population of Fife.
METHODS: All blind registrations for the period 1990-9 were studied. Those with diabetes as the first or main diagnosis were included as new diabetic blind. The prevalence of diabetes was studied in a large sample population and extrapolated to the estimated population of Fife.
RESULTS: The incidence of blindness due to diabetes was 64 (SD 24, 95% CI 49-79) per 100 000 diabetic population/year. The point prevalence of blindness due to diabetes on 31 December 1999 was 210 per 100 000 diabetic population.
CONCLUSION: The incidence of blindness due to diabetes, in a diabetic population, is now known. Without this benchmark it is impossible to assess the implementation of the St Vincent Declaration.

Entities:  

Mesh:

Year:  2001        PMID: 11222346      PMCID: PMC1723871          DOI: 10.1136/bjo.85.3.354

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Incidence of blindness in relation to diabetes. A population-based study.

Authors:  C Trautner; A Icks; B Haastert; F Plum; M Berger
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

2.  Diabetes and it's complications in a Swedish county.

Authors:  B Lundman; L Engström
Journal:  Diabetes Res Clin Pract       Date:  1998-02       Impact factor: 5.602

3.  The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry.

Authors:  B Berger; G Stenström; Y F Chang; G Sundkvist
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

Review 4.  Diabetes in the United Kingdom: some facts and figures.

Authors:  J D Nabarro
Journal:  Diabet Med       Date:  1988-12       Impact factor: 4.359

5.  Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

6.  The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy.

Authors:  E Agardh; C D Agardh; C Hansson-Lundblad
Journal:  Diabet Med       Date:  1993-07       Impact factor: 4.359

7.  Blind and partial sight registration in Avon.

Authors:  R H Grey; C J Burns-Cox; A Hughes
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

8.  Common causes of blindness and visual handicap in the west of Scotland.

Authors:  I M Ghafour; D Allan; W S Foulds
Journal:  Br J Ophthalmol       Date:  1983-04       Impact factor: 4.638

9.  Ten-year incidence of visual loss in a diabetic population.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

  9 in total
  8 in total

1.  Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa.

Authors:  R Kahloun; B Jelliti; S Zaouali; S Attia; S Ben Yahia; S Resnikoff; M Khairallah
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

2.  Visual impairment certification secondary to ARMD in Leeds, 2005-2010: is the incidence falling?

Authors:  E Rostron; M McKibbin
Journal:  Eye (Lond)       Date:  2012-04-13       Impact factor: 3.775

3.  The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre.

Authors:  Emily Greenan; Marisa Salim; Daniel Nicholas Coakley; Mark James
Journal:  Ir J Med Sci       Date:  2019-04-18       Impact factor: 1.568

4.  Registration of visual impairment due to diabetic retinopathy in a subpopulation of Cambridgeshire.

Authors:  Patel Gordon-Bennett; Aseema Misra; Wendy Newsom; Declan Flanagan
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK).

Authors:  Sobha Sivaprasad; Bhaskar Gupta; Martin C Gulliford; Hiten Dodhia; Samantha Mann; Dinesh Nagi; Jennifer Evans
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

6.  The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.

Authors:  Peter H Scanlon
Journal:  Acta Diabetol       Date:  2021-04-08       Impact factor: 4.280

7.  Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation.

Authors:  Graham P Leese; Paul Boyle; Zhiqiang Feng; Alistair Emslie-Smith; John D Ellis
Journal:  Diabetes Care       Date:  2008-08-26       Impact factor: 17.152

8.  Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015.

Authors:  Rebecca L Thomas; Stephen D Luzio; Rachel V North; Sanjiv Banerjee; Antra Zekite; Catey Bunce; David R Owens
Journal:  BMJ Open       Date:  2017-07-18       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.